SCHEMBL4539898

SCHEMBL4539898

CCCCCC[N+](C)(CC#N)CCCCCC.Cc1ccc(S(=O)(=O)[O-])cc1

nearest known ligand 0.53

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.53
LMNA P02545 3/20 0.51
CYP2C9 P11712 3/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2C19 P33261 2/20 0.51
TSHR P16473 2/20 0.51
HTT P42858 1/20 0.51
HIF1A Q16665 1/20 0.51
MCHR1 Q99705 1/20 0.42
NR1I2 O75469 1/20 0.41
CYP3A4 P08684 2/20 0.40
MAPK1 P28482 1/20 0.40
THPO P40225 1/20 0.40
GLA P06280 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 5/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
APAF1 O14727 1/20 0.35
HSP90AA1 P07900 1/20 0.35
RAD52 P43351 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5884144 1.00 KCNH2 (0.53) KCNH2LMNACYP2C9CYP2D6CYP2C19
SCHEMBL4246252 0.91 KCNH2 (0.52) KCNH2LMNACYP2C9CYP2D6CYP2C19
SCHEMBL4246458 0.91 KCNH2 (0.52) KCNH2LMNACYP2C9CYP2D6CYP2C19
SCHEMBL4535932 0.91 KCNH2 (0.52) KCNH2LMNACYP2C9CYP2D6CYP2C19
SCHEMBL5080911 0.89 KCNH2 (0.42) KCNH2LMNACYP2C9CYP2D6CYP2C19
SCHEMBL330997 0.89 LMNA (0.57) KCNH2LMNACYP2C9CYP2D6CYP2C19
SCHEMBL330797 0.89 LMNA (0.57) KCNH2LMNACYP2C9CYP2D6CYP2C19
SCHEMBL331650 0.89 LMNA (0.57) KCNH2LMNACYP2C9CYP2D6CYP2C19
SCHEMBL331299 0.89 LMNA (0.57) KCNH2LMNACYP2C9CYP2D6CYP2C19
SCHEMBL31222502 0.89 LMNA (0.57) KCNH2LMNACYP2C9CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090171111-A1 Method for Producing Sodium Chloride-Free Ammonium Nitriles CLARIANT FINANCE (BVI) LIMITED (VG) 2009-07-02 US disclosed
EP-2001835-A1 METHOD FOR PRODUCING AMMONIUM NITRILES CLARIANT INTERNATIONAL LTD. (CH) 2008-12-17 EP disclosed
EP-2001834-A1 IMPROVED METHOD FOR PRODUCING SODIUM CHLORIDE-FREE AMMONIUM NITRILES CLARIANT INTERNATIONAL LTD. (CH) 2008-12-17 EP disclosed
EP-1487955-B1 AMMONIUM NITRILES AND THE USE THEREOF AS HYDROPHOBIC BLEACHING ACTIVATORS CLARIANT PRODUKTE DEUTSCHLAND (DE) 2008-05-21 EP disclosed
WO-2007110161-A1 IMPROVED METHOD FOR PRODUCING SODIUM CHLORIDE-FREE AMMONIUM NITRILES CLARIANT INTERNATIONAL LTD (CH) 2007-10-04 WO disclosed
WO-2007110162-A1 METHOD FOR PRODUCING AMMONIUM NITRILES CLARIANT INTERNATIONAL LTD (CH) 2007-10-04 WO disclosed
US-7015185-B2 Ammonium nitriles and the use thereof as hydrophobic bleaching activators CLARIANT GMBH (DE) 2006-03-21 US disclosed
US-20040266644-A1 Ammonium nitriles and the use thereof as hydrophobic bleaching activators CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2004-12-30 US disclosed
EP-1487955-A1 AMMONIUM NITRILES AND THE USE THEREOF AS HYDROPHOBIC BLEACHING ACTIVATORS Clariant GmbH (DE) 2004-12-22 EP disclosed
WO-2003078561-A1 AMMONIUM NITRILES AND THE USE THEREOF AS HYDROPHOBIC BLEACHING ACTIVATORS CLARIANT GMBH (DE) 2003-09-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090171111-A1 Method for Producing Sodium Chloride-Free Ammonium Nitriles CBR3, MSRB3, CBR1 KCNH2 147/4885LMNA 4789/4885CYP2C9 292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.